The Washington Chapter of the American Academy of Pediatrics (WCAAP) and Washington Department of Health (WA DOH) share important information regarding the clinical and operational steps for ordering and administering nirsevimab, the monoclonal antibody product used to prevent serious respiratory syncytial virus (RSV) illness in babies.
Nirsevimab Informational Webinar
Presented by: Jamilia Sherls-Jones, DNP, MPH, RN, CDP, CPN: Director, Office of Immunization at the DOH Frank Bell, MD: Pediatric Infectious Disease Specialist at Swedish Amy Carter, MD: Chief Medical Officer and General Pediatrician at Allegro Pediatrics